Galmed Pharmaceuticals Ltd. Soared
Wed, Dec 21, 2022 at 07:09 PM
Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ) soared at $0.45, representing a gain of 41%. On Wed, Dec 21, 2022, GLMD:NASDAQ touched a New 2-Week High of $0.45. From Wed, Dec 07, 2022, the stock recorded 40.00% Up Days and 45.45% Green Days
About Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ)
Galmed Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.
Top 10 Gainers:
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Gorilla Technology Group Inc. (GRRR:NASDAQ), 69.79%
- Sintx Technologies, Inc. (SINT:NASDAQ), 57.16%
- Rekor Systems, Inc. (REKR:NASDAQ), 56.45%
- Cenntro Electric Group Limited (CENN:NASDAQ), 51.86%
- Mobile Global Esports Inc. (MGAM:NASDAQ), 45.29%
- Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ), 40.97%
- The Oncology Institute Inc. (TOI:NASDAQ), 32.51%
- E-Home Household Service Holdings Limited (EJH:NASDAQ), 32.26%
- Erayak Power Solution Group Inc. (RAYA:NASDAQ), 32.22%